Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988 May;118(5):641-4.
doi: 10.1111/j.1365-2133.1988.tb02564.x.

Site-specific melanocytic naevus counts as predictors of whole body naevi

Affiliations

Site-specific melanocytic naevus counts as predictors of whole body naevi

J S English et al. Br J Dermatol. 1988 May.

Abstract

Counts of melanocytic naevi of 2 mm or greater diameter on all body sites were conducted in 197 Caucasian adults in Scotland. Mean naevus numbers were greater in young than in older adults, and in females than in males. Naevus counts on the upper limbs, lower limbs, and trunk were strongly and significantly correlated with each other and with whole body counts. Thus, where whole body counts are impractical, counting naevi at any of these individual sites should provide a satisfactory method for studying naevus distribution in large populations.

PubMed Disclaimer

Similar articles

Cited by

  • Inherited Genetic Variants Associated with Melanoma BRAF/NRAS Subtypes.
    Thomas NE, Edmiston SN, Orlow I, Kanetsky PA, Luo L, Gibbs DC, Parrish EA, Hao H, Busam KJ, Armstrong BK, Kricker A, Cust AE, Anton-Culver H, Gruber SB, Gallagher RP, Zanetti R, Rosso S, Sacchetto L, Dwyer T, Ollila DW, Begg CB, Berwick M, Conway K; GEM Study Group. Thomas NE, et al. J Invest Dermatol. 2018 Nov;138(11):2398-2404. doi: 10.1016/j.jid.2018.04.025. Epub 2018 May 9. J Invest Dermatol. 2018. PMID: 29753029 Free PMC article.
  • Nevus density and melanoma risk in women: a pooled analysis to test the divergent pathway hypothesis.
    Olsen CM, Zens MS, Stukel TA, Sacerdote C, Chang YM, Armstrong BK, Bataille V, Berwick M, Elwood JM, Holly EA, Kirkpatrick C, Mack T, Bishop JN, Østerlind A, Swerdlow AJ, Zanetti R, Green AC, Karagas MR, Whiteman DC. Olsen CM, et al. Int J Cancer. 2009 Feb 15;124(4):937-44. doi: 10.1002/ijc.24011. Int J Cancer. 2009. PMID: 19035450 Free PMC article.
  • Identifying Persons at Highest Risk of Melanoma Using Self-Assessed Risk Factors.
    Williams LH, Shors AR, Barlow WE, Solomon C, White E. Williams LH, et al. J Clin Exp Dermatol Res. 2011;2(6):1000129. doi: 10.4172/2155-9554.1000129. J Clin Exp Dermatol Res. 2011. PMID: 22229112 Free PMC article.
  • Associations of MC1R Genotype and Patient Phenotypes with BRAF and NRAS Mutations in Melanoma.
    Thomas NE, Edmiston SN, Kanetsky PA, Busam KJ, Kricker A, Armstrong BK, Cust AE, Anton-Culver H, Gruber SB, Luo L, Orlow I, Reiner AS, Gallagher RP, Zanetti R, Rosso S, Sacchetto L, Dwyer T, Parrish EA, Hao H, Gibbs DC, Frank JS, Ollila DW, Begg CB, Berwick M, Conway K; GEM Study Group. Thomas NE, et al. J Invest Dermatol. 2017 Dec;137(12):2588-2598. doi: 10.1016/j.jid.2017.07.832. Epub 2017 Aug 24. J Invest Dermatol. 2017. PMID: 28842324 Free PMC article.
  • Association of Interferon Regulatory Factor-4 Polymorphism rs12203592 With Divergent Melanoma Pathways.
    Gibbs DC, Orlow I, Bramson JI, Kanetsky PA, Luo L, Kricker A, Armstrong BK, Anton-Culver H, Gruber SB, Marrett LD, Gallagher RP, Zanetti R, Rosso S, Dwyer T, Sharma A, La Pilla E, From L, Busam KJ, Cust AE, Ollila DW, Begg CB, Berwick M, Thomas NE; GEM Study Group. Gibbs DC, et al. J Natl Cancer Inst. 2016 Feb 8;108(7):djw004. doi: 10.1093/jnci/djw004. Print 2016 Jul. J Natl Cancer Inst. 2016. PMID: 26857527 Free PMC article.